secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001636422-24-000004
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst reports preliminary 2023 revenue and EBITDA above guidance; guides 2024 EBITDA ~$25M
--------------------------------------------------------------------------------

- Preliminary Q4 2023 total revenue above guidance midpoint (range $70.1M–$75.1M); Adjusted EBITDA at or above midpoint ($0.3M–$2.3M).
- Preliminary FY 2023 total revenue above guidance midpoint ($291M–$296M); Adjusted EBITDA at or above midpoint ($10M–$12M).
- 2023 Dollar-Based Retention Rate approx 100%, below forecast 102%-110%, due to timing delays on large TEMS expansions.
- Anticipates 2024 Adjusted EBITDA of ~$25M and 2025 Adjusted EBITDA margin target of 10% or greater.
- Expects improvement in 2024 net new DOS Subscription Client bookings and retention rate relative to 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000004/0001636422-24-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000004/hcat-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001636422-24-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer